Drugs / GZR101-80
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07387003 | Apr 2026 → Feb 2027 expected | type 2 diabetes mellitus | Gan & Lee Pharmaceuticals. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GZR101-80 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07387003 ↗ |
| Route | Subcutaneous | “Administered SC” NCT07387003 ↗ |